Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation (ABUS)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
4. 56
-0.18
-3.7975%
$
910.65M Market Cap
- P/E Ratio
- Div Yield
1.6M Volume
-0.45 Eps
$ 4.74
Previous Close
Add Transaction
Day Range
4.55 4.82
Year Range
3.08 5.38
Want to track ABUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Arbutus Biopharma Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
EM
Eric Myers Carrera Capital Advisors
252,159 $1.13M $1.15M $15,129.04 1.33%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
41,664 $151,105.28 $189,987.84 $38,882.56 25.73%
BM
Berkeley Meredith Hughes Financial Services LLC
1 $4.5 $4.56 $0.06 1.33%
Cura Wealth Advisors LLC
Cura Wealth Advisors LLC Cura Wealth Advisors LLC
15,000 $49,050 $68,400 $19,350 39.45%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
4,300 $14,894.79 $19,608 $4,713.21 31.64%
Robert L. Wofchuck
Robert L. Wofchuck Ledgewood Wealth Advisors LLC
278,436 $696,090 $1.27M $573,578.16 82.4%
David R. Hess
David R. Hess Wealth Management Associates Inc.
131,870 $446,394.97 $601,327.2 $154,932.23 34.71%